Position in TARS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,235,735
+$424,136 QoQ
Shares Held
67,298
+23.9% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Derivatives in TARS
reported options exposure · as of Mar 31, 2024CallValue
$836,050
CallShares
23,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. TARS ranks #74 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in TARS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,235,735 | 67,298 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $3,811,599 | 54,335 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,255,384 | 51,971 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,412,322 | 40,591 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $923,383 | 22,794 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,838,531 | 35,790 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,115,576 | 38,208 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,099,676 | 33,435 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $428,084 | 15,750 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $836,050 | 23,000 | Call | Defined | 2024-05-10 | |
| 2024-03-31 | $513,333 | 14,122 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $242,594 | 11,980 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $73,744 | 4,150 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $145,698 | 8,063 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $9,301 | 740 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $13,179 | 899 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,776 | 279 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $17,855 | 1,223 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,315 | 316 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $48,262 | 2,145 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $20,731 | 962 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $11,620 | 401 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $13,310 | 413 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $47,570 | 1,151 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||